August 2010
1031
rated to dryness, and then the methanolic solution was adsorbed on silica gel
and subjected to silica gel CC (20 g, Fϭ22 mm, Lϭ11 cm) with CHCl3
(100 ml) and CHCl3–MeOH (19 : 1, 100 ml, 9 : 1, 100 ml, 17 : 3, 100 ml, and
7 : 3, 300 ml), 12 ml fractions being collected. Crotalionol A (1a) (1.8 mg,
72%) and D-glucose (1.6 mg, 86%) were recovered in fractions 26—31 and
36—42, respectively. Crotalionol A (1a): an amorphous powder, [a]D27
1.06 (3H, s, H3-12), H-2b could not be assigned, due to overlapping signals;
HR-ESI-TOF-MS (positive-ion mode) m/z: 697.2213 [MϩNa]ϩ (Calcd for
C33H36O8F6Na, 697.2206). Crotalionol B 3,9-di-O-(S)-MTPA ester (2c): an
amorphous powder, 1H-NMR (CDCl3, 400 MHz) d: 7.46—7.62 (4H, m, aro-
matic protons), 7.33—7.43 (6H, m, aromatic protons), 5.56 (1H, qd, Jϭ6,
6 Hz, H-9), 5.43 (1H, d, Jϭ6 Hz, H-8), 5.43 (1H, ddd, Jϭ12, 9, 5 Hz, H-3),
Ϫ34.2° (cϭ0.12, MeOH); 1H-NMR (CD3OD, 400 MHz) d: 5.35 (1H, d, 3.61 (3H, q, Jϭ1 Hz, –OCH3), 3.56 (3H, q, Jϭ1 Hz, –OCH3), 3.16 (1H, d,
Jϭ6 Hz, H-8), 4.27 (1H, qd, Jϭ6, 6 Hz, H-9), 3.95 (1H, ddd, Jϭ12, 9, 5 Hz, Jϭ9 Hz, H-4), 1.88 (1H, dd, Jϭ12, 5 Hz, H-2a), 1.42 (3H, s, H3-11), 1.42
H-3), 2.99 (1H, d, Jϭ9 Hz, H-4), 1.82 (1H, dd, Jϭ12, 5 Hz, H-2a), 1.36 (3H,
s, H3-13), 1.34 (1H, dd, Jϭ12, 12 Hz, H-2b), 1.30 (3H, s, H3-11), 1.25 (3H,
(3H, d, Jϭ6 Hz, H3-10), 1.36 (3H, s, H3-13), 1.02 (3H, s, H3-12), H-2b could
not be assigned, due to overlapping signals; HR-ESI-TOF-MS (positive-ion
d, Jϭ6 Hz, H3-10), 1.06 (3H, s, H3-12); 13C-NMR (CD3OD, 100 MHz) d: mode) m/z: 697.2204 [MϩNa]ϩ (Calcd for C33H36O8F6Na, 697.2206).
200.8 (C-7), 117.6 (C-6), 100.3 (C-8), 82.2 (C-4), 74.7 (C-5), 69.2 (C-3),
67.2 (C-9), 47.6 (C-2), 35.6 (C-1), 32.9 (C-12), 29.4 (C-11), 26.7 (C-13),
NaBH4 Reduction of Citrosides A (10) and B (11) to the Correspond-
ing Alcohols (10a, 10b) To a solution of citroside A (10) (10 mg) in 0.5 ml
23.5 (C-10); HR-ESI-TOF-MS (positive-ion mode) m/z: 265.1409 of MeOH was added 10 mg of CeCl3·7H2O and then 2 mg of NaBH4, the re-
[MϩNa]ϩ (Calcd for C13H22O4Na, 265.1410). D-Glucose: [a]D27 ϩ35.2° action mixture being stirred for 5 min at 25 °C. Excess NaBH4 was quenched
(cϭ0.11, H2O, 24 h after being dissolved in the solvent).
by the addition of 100 ml of (CH3)2CO and then the reaction mixture was
Preparation of Crotalionol A (R)- and (S)-MTPA 3,9-Diesters (1b, 1c) evaporated and purified by preparative TLC (developed with CHCl3–
from 1a A solution of 1a (1.1 mg) in 1 ml of dehydrated CH2Cl2 was re- MeOH–H2O, 15 : 6 : 1, and then eluted with CHCl3–MeOH, 1 : 1) to afford
acted with (R)-MTPA (66 mg) in the presence of EDC (17 mg) and 4-DMAP 1.7 mg of 10a. Citroside B (11) (1.5 mg) was similarly reduced to give
(12 mg), the mixture being occasionally stirred at 25 °C for 6 h. After the ad-
dition of 1 ml of CH2Cl2, the solution was washed with H2O (1 ml), 5% HCl
(1 ml), NaHCO3-saturated H2O, and then brine (1 ml), successively. The or-
0.5 mg of 11a. 10a: CD De (nm): ϩ2.32 (226) (cϭ4.90ϫ10Ϫ5 M, MeOH).
11a: CD De (nm): ϩ1.29 (225) (cϭ5.15ϫ10Ϫ5 M, MeOH).
HPLC Separation of 10a and 11a Compound 10a was separated by
ganic layer was dried over Na2SO4 and then evaporated under reduced pres- HPLC (MeOH–H2O, 2 : 3) to give 0.4 mg of 10b and 0.2 mg of 10c from the
sure. The residue was purified by preparative TLC [silica gel (0.25 mm peaks at 11 min and 12 min, respectively. Compound 11a was similarly sepa-
thickness), being applied for 18 cm, development with CHCl3–(CH3)2CO
(19 : 1) for 9 cm, and then eluted with CHCl3–MeOH (9 : 1)] to furnish an
ester, 1b (0.5 mg, 29%). Through a similar procedure, 1c (1.0 mg, 45%) was (1H, d, Jϭ6 Hz, H-8), 4.50 (1H, d, Jϭ8 Hz, H-1Ј), 4.28 (2H, overlapped, H-
prepared from 1a (0.8 mg) using (S)-MTPA (46 mg), EDC (17 mg), and 4- 3, 9), 3.79 (1H, dd, Jϭ12, 3 Hz, H-6Јa), 3.64 (1H, dd, Jϭ12, 5 Hz, H-6Јb),
rated by HPLC to give 50 mg of 11b and 50 mg of 11c from the peaks at
1
20 min and 23 min, respectively. 10b: H-NMR (CD3OD, 400 MHz) d: 5.33
DMAP (12 mg). Crotalionol A 3,9-di-O-(R)-MTPA ester (1b) of 1a: an
3.18—3.36 (3H, m, H-3Ј, 4Ј, 5Ј), 3.12 (1H, dd, Jϭ9, 8 Hz, H-2Ј), 2.41 (1H,
amorphous powder; 1H-NMR (CDCl3, 400 MHz) d: 7.46—7.59 (4H, m, aro- ddd, Jϭ13, 4, 2 Hz, H-4a), 1.84 (1H, ddd, Jϭ13, 4, 2 Hz, H-2a), 1.41 (3H, s,
matic protons), 7.34—7.43 (6H, m, aromatic protons), 5.55 (1H, qd, Jϭ6,
6 Hz, H-9), 5.46 (1H, ddd, Jϭ12, 9, 5 Hz, H-3), 5.41 (1H, dd, Jϭ6, 1 Hz, H-
8), 3.59 (3H, s, –OCH3), 3.54 (3H, s, –OCH3), 3.29 (1H, d, Jϭ9 Hz, H-4),
1.96 (1H, dd, Jϭ12, 5 Hz, H-2a), 1.45 (1H, dd, Jϭ12, 12 Hz, H-2b), 1.42
(3H, d, Jϭ6 Hz, H3-10), 1.37 (3H, s, H3-11), 1.34 (3H, s, H3-13), 0.96 (3H,
H3-13), 1.29 (3H, s, H3-12), 1.26 (3H, d, Jϭ6 Hz, H3-10), 1.09 (3H, s, H3-
11), H-2b and 4b could not be assigned, due to overlapping signals; CD De
(nm): ϩ1.20 (226) (cϭ5.15ϫ10Ϫ5 M, MeOH); HR-ESI-TOF-MS (positive-
ion mode) m/z: 411.1985 [MϩNa]ϩ (Calcd for C19H32O8Na, 411.1989). 10c:
1H-NMR (CD3OD, 400 MHz) d: 5.32 (1H, d, Jϭ6 Hz, H-8), 4.50 (1H, d,
s, H3-12); HR-ESI-TOF-MS (positive-ion mode) m/z: 697.2209 [MϩNa]ϩ Jϭ8 Hz, H-1Ј), 4.27 (2H, overlapped, H-3, 9), 3.79 (1H, dd, Jϭ12, 3 Hz, H-
(Calcd for C33H36O8F6Na, 697.2206). Crotalionol A 3,9-di-O-(S)-MTPA 6Јa), 3.64 (1H, dd, Jϭ12, 5 Hz, H-6Јb), 3.18—3.36 (3H, m, H-3Ј, 4Ј, 5Ј),
ester (1c) of 1a: an amorphous powder, 1H-NMR (CDCl3, 400 MHz) d:
7.48—7.67 (4H, m, aromatic protons), 7.34—7.42 (6H, m, aromatic pro-
tons), 5.53 (1H, qd, Jϭ6, 6 Hz, H-9), 5.48 (1H, d, Jϭ6 Hz, H-8), 5.47 (1H,
3.12 (1H, dd, Jϭ9, 8 Hz, H-2Ј), 2.41 (1H, ddd, Jϭ13, 4, 2 Hz, H-4a), 1.84
(1H, Jϭ13, 4, 2 Hz, H-2a), 1.42 (3H, s, H3-13), 1.29 (3H, s, H3-12), 1.26
(3H, d, Jϭ6 Hz, H3-10), 1.08 (3H, s, H3-11), H-2b and 4b could not be as-
ddd, Jϭ12, 9, 5 Hz, H-3), 3.60 (3H, q, Jϭ1 Hz, –OCH3), 3.51 (3H, q, signed, due to overlapping signals; CD De (nm): ϩ1.65 (226) (cϭ5.15ϫ
Jϭ1 Hz, –OCH3), 3.34 (1H, d, Jϭ9 Hz, H-4), 1.90 (1H, dd, Jϭ12, 5 Hz, H-
10Ϫ5 M, MeOH); HR-ESI-TOF-MS (positive-ion mode) m/z: 411.1983
2a), 1.41 (1H, dd, Jϭ12, 12 Hz, H-2b), 1.38 (3H, s, H3-11), 1.36 (3H, d, [MϩNa]ϩ (Calcd for C19H32O8Na, 411.1989). 11b: 1H-NMR (CD3OD,
Jϭ6 Hz, H3-10), 1.36 (3H, s, H3-13), 1.01 (3H, s, H3-12); HR-ESI-TOF-MS 400 MHz) d: 5.43 (1H, d, Jϭ6 Hz, H-8), 4.53 (1H, d, Jϭ 8Hz, H-1Ј), 4.51
(positive-ion mode) m/z: 697.2204 [MϩNa]ϩ (Calcd for C33H36O8F6Na,
697.2206).
Enzymatic Hydrolysis of Crotalionoside B (2) Crotalionoside B (2)
(1H, overlapped with HDO signal, H-9), 4.30 (1H, m, H-3), 3.80 (1H, dd,
Jϭ12, 2 Hz, H-6Јa), 3.65 (1H, dd, Jϭ12, 5 Hz,. H-6Јb), 3.12—3.36 (4H, m,
H-2Ј, 3Ј, 4Ј, 5Ј), 2.41 (1H, m, H-4a), 1.38 (1H, m, H-2a), 1.38 (3H, s, H3-
(0.9 mg) was similarly hydrolyzed with emulsin (1.5 mg) and crude hes- 13), 1.33 (3H, d, Jϭ6 Hz, H3-10), 1.30 (3H, s, H3-12), 1.08 (3H, s, H3-11),
peridinase (1.5 mg). The reaction mixture was evaporated to dryness, and H-2b and 4b could not be assigned, due to overlapping signals; HR-
then the methanolic solution was adsorbed on silica gel and subjected to sil- ESI-TOF-MS (positive-ion mode) m/z: 411.1991 [MϩNa]ϩ (Calcd for
1
ica gel CC (7 g, Fϭ10 mm, Lϭ17 cm) with CHCl3 (50 ml) and CHCl3– C19H32O8Na, 411.1989). 11c: H-NMR (CD3OD, 400 MHz) d: 5.40 (1H, d,
MeOH (19 : 1, 50 ml, 9 : 1, 50 ml, 17 : 3, 50 ml, and 7 : 3, 150 ml), 5 ml frac-
tions being collected. Crotalionol B (2a) (0.4 mg, 74%) and D-glucose
Jϭ6 Hz, H-8), 4.53 (1H, d, Jϭ8 Hz, H-1Ј), 4.51 (1H, overlapped with HDO
signal, H-9), 4.30 (1H, m, H-3), 3.80 (1H, dd, Jϭ12, 2 Hz, H-6Јa), 3.65 (1H,
(0.2 mg, 50%) were recovered in fractions 28—34 and 45—53, respectively. dd, Jϭ12, 5 Hz, H-6Јb), 3.12—3.36 (4H, m, H-2Ј, 3Ј, 4Ј, 5Ј), 2.41 (1H, m,
Crotalionol B (2a): amorphous powder; [a]D25 ϩ3.77° (cϭ0.038, MeOH);
H-4a), 1.83 (1H, m, H-2a), 1.40 (3H, s, H3-13), 1.31 (3H, d, Jϭ6 Hz, H3-10),
1H-NMR (CD3OD, 400 MHz) d: 5.35 (1H, d, Jϭ6 Hz, H-8), 4.28 (1H, qd, 1.29 (3H, s, H3-12), 1.06 (3H, s, H3-11), H-2b and 4b could not be assigned,
Jϭ6, 6 Hz, H-9), 3.94 (1H, ddd, Jϭ12, 9 5 Hz, H-3), 3.00 (1H, d, Jϭ9 Hz, due to overlapping signals; HR-ESI-TOF-MS (positive-ion mode) m/z:
H-4), 1.82 (1H, dd, Jϭ12, 5 Hz, H-2a), 1.36 (3H, s, H3-13), 1.35 (1H, dd, 411.1984 [MϩNa]ϩ (Calcd for C19H32O8Na, 411.1989).
Jϭ12, 12 Hz, H-2b), 1.30 (3H, s, H3-11), 1.25 (3H, d, Jϭ6 Hz, H3-10), 1.06
(3H, s, H3-12); 13C-NMR (CD3OD, 100 MHz) d: 200.7 (C-7), 117.6 (C-6),
100.4 (C-8), 82.2 (C-4), 74.7 (C-5), 69.2 (C-3), 67.2 (C-9), 48.0 (C-2), 35.7
(C-1), 32.7 (C-12), 29.4 (C-11), 26.8 (C-13), 23.5 (C-10); HR-ESI-TOF-MS
Enzymatic Hydrolysis of Crotalionoside C (3) Crotalionoside C (3)
(4.5 mg) was hydrolyzed with emulsin (4.5 mg) and crude hesperidinase
(4.0 mg) at 37 °C for 24 h. The reaction mixture was evaporated to dryness,
and then the methanolic solution was adsorbed on silica gel and subjected to
(positive-ion mode) m/z: 265.1408 [MϩNa]ϩ (Calcd for C13H22O4Na, silica gel CC (25 g, Fϭ22 mm, Lϭ13 cm) with CHCl3 (100 ml) and
265.1410).
CHCl3–MeOH (19 : 1, 100 ml, 9 : 1, 100 ml, 17 : 3, 100 ml, and 7 : 3, 300 ml),
Preparation of Crotalionol B (R)- and (S)-MTPA 3,9-Diesters (2b, 2c) 5 ml fractions being collected. Crotalionol C (3a) (2.2 mg, 86%) and glucose
from 2a From 2a (0.2 mg each), 2b (0.2 mg, 36%) and 2c (0.3 mg, 54%)
(1.4 mg, 67%) were recovered in fractions 21—24 and fractions 49—55,
were prepared with the respective amounts of (R)- and (S)-MTPA (51, repectively. Crotalionol C (3a): Amorphous powder; [a]D24 Ϫ23.1° (cϭ0.15,
1
41 mg), EDC (13, 15 mg), and 4-DMAP (10, 18 mg). Crotalionol B 3,9-di-
O-(R)-MTPA ester (2b): an amorphous powder, 1H-NMR (CDCl3, 400 MHz)
d: 7.49—7.58 (4H, m, aromatic protons), 7.36—7.43 (6H, m, aromatic pro-
tons), 5.58 (1H, qd, Jϭ6, 6 Hz, H-9), 5.52 (1H, d, Jϭ6 Hz, H-8), 5.46 (1H,
ddd, Jϭ12, 9, 5 Hz, H-3), 3.58 (3H, q, Jϭ1 Hz, –OCH3), 3.51 (3H, q,
Jϭ1 Hz, –OCH3), 3.28 (1H, d, Jϭ9 Hz, H-4), 2.00 (1H, dd, Jϭ12, 5 Hz, H-
2a), 1.39 (3H, s, H3-11), 1.36 (3H, d, Jϭ6 Hz, H3-10), 1.32 (3H, s, H3-13),
MeOH); H-NMR (CD3OD, 400 MHz) d: 5.74 (1H, d, Jϭ16 Hz, H-7), 5.70
(1H, dd, Jϭ16, 5 Hz, H-8), 4.32 (1H, br dd, Jϭ6, 6 Hz, H-3), 4.29 (1H, qd,
Jϭ6, 5 Hz, H-9), 1.95 (1H, ddd, Jϭ12, 6, 2 Hz, H-4a), 1.77 (1H, ddd, Jϭ12,
6, 2 Hz, H-2a), 1.65 (1H, d, Jϭ12 Hz, H-4b), 1.59 (1H, d, Jϭ12 Hz, H-2b),
1.40 (3H, s, H3-11), 1.24 (3H, d, Jϭ6 Hz, H3-10), 1.17 (3H, s, H3-13), 0.86
(3H, s, H3-12); 13C-NMR (CD3OD, 100 MHz) d: 136.2 (C-8), 124.6 (C-7),
92.7 (C-6), 82.2 (C-5), 76.7 (C-3), 69.3 (C-9), 49.4 (C-2), 48.7 (C-4), 44.5